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Abstract
Background: Adipocyte volume (fat accumulation) and cell number (adipogenesis) is increased in obese
individuals. Our objective was the identification of dietary constituents with inhibitory effects on triglyceride
formation during adipogenesis. Therefore an in vitro adipose cell assay in murine C3H10 T1/2 cells was developed,
which enabled rapid quantification of intracellular fat droplet accumulation during adipocyte differentiation. Results
were corroborated by expression levels of several specific adipogenic and lipogenic genes which are known to
regulate triglyceride accumulation.
Methods: C3H10 T1/2 adipocyte differentiation was conducted with rosiglitazone in the presence of test compounds
for 7 days. Accumulation of intracellular lipid droplets was measured using the Cellomics
® ArrayScan
® VTI HCS reader
and SpotDetector
® BioApplication from ThermoFisher. Fluorescent images were automatically acquired and analysed
employing the fluorescent dyes BODIPY
® 493/503 and Hoechst 33342, for staining neutral lipids and localisation of
nuclei, respectively. The expression levels of adipogenic and lipogenic genes, such as PPARa and PPARg,C / E B P a,a P 2 ,
adiponectin, LPL and HSL, CPT-1b, ACC1, Glut4 and FAS, were determined by quantitative RT-PCR. Dietary ingredients
including PUFAs, carotenoids, polyphenols and catechins were tested for their effect on lipid accumulation.
Results: The ω-3 PUFAs docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), the carotenoid b-carotene
and hydroxytyrosol exhibited the strongest inhibitory effects on the rosiglitazone-stimulated lipid formation. (all-E)-
lycopene and epigallocatechin gallate (EGCG) showed a moderate inhibition, whereas resveratrol did not reduce fat
droplet formation. Additionally, it was demonstrated that adipogenic and lipogenic gene expression was
attenuated. DHA, b-carotene and hydroxytyrosol inhibited the gene expression of PPARg, C/EBPa, aP2 and CPT-1b.
Conclusion: This in vitro assay in differentiating adipocytes enables automated detection and quantification of changes
in lipid droplet number, size and intensity. The observed inhibitory effects of identified dietary constituents such as ω-3
PUFAs and b-carotene correlate with the modulation of genes involved in adipocyte differentiation.
Background
The metabolic disorder obesity leads to various diseases
such as hypertension, type-2-diabetes, respiratory compli-
cations and coronary heart disease [1]. This accounts for
the numerous studies on cellular and molecular processes
underlying fat metabolism in recent years [2,3].
Adipocytes are specialised cells that store triacylglycer-
ides (TGs) in times of energy excess and release energy by
lipolysis during energy shortage [2]. A constant positive
energy balance leads to an excessive fat accumulation in
white adipose tissue (WAT). Two mechanisms make this
possible: (1) hypertrophy of adipocytes and (2) hyperplasia
of proliferating pre-adipocytes into differentiated adipo-
c y t e s[ 4 ] .T h i sc o m p l e xp r o c e s sc a l l e da d i p o g e n e s i si s
sequentially regulated by several transcription factors such
as peroxisome proliferator-activated receptor gamma
(PPARg) [5], CCAAT/enhancer binding proteins (C/EBPa,
C/EBPb and C/EBPδ) [6] and the adipocyte determination
and differentiation factor 1 (ADD1/SREBP-1c) [3]. How-
ever, WAT is also an endocrine tissue that secretes meta-
bolically active substances (adipokines), which function as
feedback signals or lead to immunological responses [2].
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adipocytes may regulate the amount of adipose tissue [7].
This has triggered the discovery of pharmacological inhibi-
tors of adipogenesis and intensified the search for dietary
ingredients with similar properties [8]. Food constituents
such as polyphenols or carotenoids are dietary substances
that are precursors of, or function as, signalling molecules.
Most of these substances are plant-derived, being present
in fruits, vegetables and nuts; likewise, polyunsaturated
fatty acids (PUFAs) in fish and algae have similar proper-
ties. Many food ingredients have been described as modu-
lators of adipocyte differentiation e.g. dietary PUFAs (for
review see Madsen et al.[ 9 ] ) .
Several cell models exist to simulate differentiation of
pre-adipocytes in vitro, the most widely-used being the
3T3-L1 cell line [10] derived from 3T3 cells [11].
Another commonly-employed model is the multipotent
embryonic fibroblast cell line C3H10 T1/2 [12]. Pre-adi-
pocyte differentiation is assessed through visualisation of
accumulated fat droplets via neutral lipid staining. Alter-
natively, late adipocyte differentiation markers and genes
related to lipid metabolism, such as lipoprotein lipase
(LPL) [13], adipocyte fatty acid binding protein (aP2)
[14], fatty acid synthase (FAS) [15], hormone-sensitive
lipase (HSL) [16] or carnitine palmitoyltransferase 1
(CPT-1), can be measured.
The identification of bioactive compounds that might
reduce excessive WAT requires valid in vitro test sys-
tems that allow for the investigation of a greater number
of compounds and rapid quantitative detection of rele-
vant fat cell differentiation features.
The main objective of the present investigation was to
identify the effects of food constituents that could modu-
late the differentiation of C3H10 T1/2 cells into mature
adipocytes and the concomitant accumulation of cytoso-
l i cT G s .F o rt h i sp u r p o s ew eh a v ed e v e l o p e dan e w
morphological, high content, cell assay (HCA) using the
Cellomics
® ArrayScan
® VTI HCS Reader and the Spot-
Detector
® BioApplication software from ThermoFisher.
Several chemical classes of dietary ingredients, such as
PUFAs, carotenoids, polyphenols and catechins, were
tested in this assay. Furthermore we examined the effects
of these compounds on expression levels of genes known
to play key roles in adipocyte differentiation and fat
metabolism. Our data demonstrate that the HCA assay is
av a l u a b l es u b s t i t u t ef o rt h e commonly-used Oil Red O
procedure [17], enabling improved in situ quantification
of fat droplet number, size and intensity in adipocytes.
Methods
Materials
Dulbecco’s modified Eagle’s cell culture medium
(DMEM), penicillin G (10000 units/ml) and streptomy-
cin (10000 μg/ml) solution (pen/strep), L-glutamine
(100×, 200 mM) and phosphate-buffered saline without
Ca
2+ and Mg
2+ (PBS (-/-)) were from GIBCO™ (Grand
Island, NY, USA). Fetal calf serum (FCS) and trypsin
were purchased from AMIMED
® (BioConcept, Allsch-
wil, Switzerland). FALCON
® culture flasks were from
BECTON DICKINSON (Franklin Lakes, NJ, USA) and
24-well plates coated with collagen type I were supplied
by Greiner bio-one (Frickenhausen, Germany).
Rosiglitazone was purchased from Shanco Interna-
tional (NJ, USA) and recombinant bovine insulin
(dissolved in H2O), resveratrol and ω-3 PUFAs, docosa-
hexaenoic acid (DHA) and eicosapentaenoic acid (EPA),
were from Sigma-Aldrich (St. Louis, MO, USA). 3-hydro-
xytyrosol (HT) was from Cayman Chemicals (Ann Abor,
MI, USA). Epigallocatechin gallate (EGCG, Teavigo™)
and carotenoids were supplied by DSM Nutritional Pro-
ducts Ltd (Basel, Switzerland). Carotenoids were dissolved
in tetrahydrofurane (THF). All other test compounds were
dissolved in dimethylsulfoxide (DMSO).
Fluorescent dyes - Hoechst 33342 and BODIPY
® 493/
503 - were obtained from Molecular Probes™ (Eugene,
OR, USA). The CytoTox
® non-radioactive cytotoxicity
assay kit was purchased from Promega (Fitchburg, WI,
USA). Primers and probes were synthesised by Applied
Biosystems (PE Biosystems, Foster City, CA, USA) or by
Sigma Genosys (St. Louis, MO, USA).
Cell culture
Mouse embryonic fibroblast cells C3H10 T1/2 [12] were
from ATCC-LGC (Middlesex, UK) and cultured accord-
ing to the supplier’s protocol. Briefly, cells were grown
in high glucose (4.5 g/ml) DMEM supplemented with
10% FCS and 0.5% pen/strep (v/v) (growth medium;
GM) at 37°C and 5% CO2. Cells were cultured until
they reached 80 - 90% confluence; they were used
between passage 6 and 20 for the experiments described
below.
Adipocyte differentiation assay
C3H10 T1/2 cells were plated (2 × 10
5 cells/cm
2) in col-
lagen-I-coated 24-well plates and maintained in phenol
red-free GM supplemented with 2 mM L-glutamine
(GM1) until 1 day post-confluence (day 0). Differentia-
tion medium (DM) containing 200 nM bovine insulin
and 10 μM rosiglitazone was then added [18]. C3H10
T1/2 pre-adipocytes were either cultured in DM only
(positive control) or in DM supplemented with different
doses of test compounds (0.5 - 25 μM) for 4 days (gene
expression study) or 7 days. Each treatment was
performed in triplicate. The final DMSO and/or THF
concentration was adjusted for all treatments and con-
trols to 0.2% and/or 0.1%, respectively, and medium and
compounds were renewed every other day. Cells were
lysed after 96 h or, after 1 week treatment, fixed with
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below).
Staining procedures
Adipocytes were stained with Oil Red O or with the
fluorescent dyes Hoechst 33342 (Hoe) and BODIPY
®
493/503 (BP). In brief, fixed cells were first washed
twice with PBS (-/-). For the Oil Red O staining, cells
were incubated with 200 μlo fO i lR e dOs o l u t i o n
(0.33% w/v in 60% isopropanol) for 20 min at room
temperature (RT). The fluorescent staining comprised
addition of 200 μlH o e / B Ps o l u t i o n( 3μg/ml Hoe, 0.75
μg/ml BP in PBS (-/-)) per well, followed by incubation
in the dark at RT for 30 min. Before analysis, the cells
were washed twice with PBS (-/-).
Visualisation of Oil Red O stained adipocytes and
quantification of Oil Red O
Images of Oil Red O stained adipocytes were acquired
using a Nikon Coolpix 990 camera at 20× magnification
and further edited with Adobe
® Photoshop
® CS2
version 9.
To quantify staining of fat droplets, Oil Red O stain
was extracted by adding isopropanol to each well imme-
diately after removal of the wash solution (300 μlp e r
well). Plates were incubated for 10 min at RT; two ali-
quots of 100 μl were transferred to 96-well plates and
read immediately at 510 nm (Spectra Max Plus 384,
Molecular Devices, CA USA). After subtraction of the
background value (wells without cells, but treated with
medium; non-specific binding), the differentiation of
treated cells was calculated as percent of positive
control.
Automated determination of lipid accumulation in
adipocytes
Lipid droplets were quantified with the Cellomics
®
ArrayScan
® VTI HCS Reader (500 series, version 5.6.1.4 -
0.63×, ThermoFisher Scientific). Fat droplets were
detected with the provided SpotDetector
® BioApplication.
The fluorescent dye, BODIPY
® 493/503, was used to
visualise and quantify fat droplets (number, area, intensity)
in differentiated C3H10 T1/2 adipocytes, while nuclei
were stained using the Hoechst 33342 dye. The method is
based on a two-channel assay, which uses a 40× objective
(NA 0.5), a Hamamatsu ORCA-ER digital camera in com-
bination with a 0.63× coupler and Carl Zeiss microscope
optics for image acquisition. Images were acquired in high
resolution (1024 × 1024, 1 × 1) and auto focus mode
(1024 × 1024, 4 × 4) resulting in a field width of 262
microns. Channel one (Ch1) applies the XF93-Hoechst
filter and is the focus channel in which objects (nuclei) are
identified, and the spots (fat droplets) are detected in
channel two (Ch2, XF93-FITC filter).
The default settings of the SpotDetector.V2 assay
algorithm version 4.1 were altered such that, in Ch2,
thresholds were set to ensure that only fat droplets of a
certain size and intensity were selected for analysis of
100 fields per well (Table 1). The data of each channel
were reported on a “per field” basis.
Cell viability
Cell viability was assessed using the CytoTox
® non-
radioactive cytotoxicity assay kit (lactate dehydrogenase
(LDH) determination) and by calculating the relative
cell number according to the following equation: cell
number (%) = (average number of cells per fields [treat-
ment] * 100/average number of cells per fields [con-
trol]). Cytotoxic effects of the compounds were rated by
comparison of the LDH levels in the supernatants of
compound-treated and untreated cells at day 7. Nuclei
were counted with the ArrayScan
® reader.
Gene expression study
Total mRNA was extracted using the RNeasy
® 96 Kit
(Qiagen, Hilden, Germany) and quantified with the
RiboGreen
® Kit (Invitrogen, Molecular Probes™,
Eugene, OR, USA) according to the manufacturer’s
protocols. RNA quality was assessed using RNA 6000
Nano Chips for the Agilent 2100 Bioanalyzer (Agilent
Technologies, USA). For first strand cDNA synthesis
650 ng total RNA was reverse-transcribed using the
Omniscript
® R TK i tf r o mQ i a g e n( 2 0μl reaction mix),
random primers from Promega and RNaseOUT™ from
Invitrogen. After three incubation steps (60 min at 37°C,
Table 1 Protocol parameters differing from the standard
SpotDetector
® algorithm
Object Identification
Channel 1 Method: FixedThreshold
Value: 125
Channel 2 Method: TriangThreshold
Value: 0.499
Object Selection Parameter Min Max
Channel 1 ObjectArea: 100 6000
Channel 2 SpotAreaCh2: 3 10000
SpotAvgIntenCh2: 30 4095
SpotTotalIntenCh2: 1691 4411431044
Assay Parameters
BackgroundCorrection: 140
ObjectSegmentationCh1: 20
SmoothFactorCh1: 5
SpotDetectRadiusCh2: 15
TargetCircModifierCh2: 512
PixelSize: 0.256 microns
The alteration of assay parameters enables adjustment of the algorithm to
different biological cell models. Displayed values are pixel number.
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with DEPC-treated water to 260 μl and stored at -20°C.
Quantitative TaqMan™ RT-PCR was performed using
an ABI-PRISM
® 7900 HT Sequence Detection System
(PE Biosystems, Foster City, CA, USA) and MicroAmp
®
Optical 96-well reaction plates (PE Biosystems, Foster
City, CA, USA). Briefly, 5 μl cDNA was added to 20 μl
reaction mixture, containing 1 × Universal Master Mix
(PE Biosystems, Rotkreuz, Switzerland), 300 nM PCR
primers (forward and reverse), and 100 nM TaqMan™
probe (FAM-TAMRA) for the gene of interest. 18S
rRNA was used as endogenous control (EC), with pri-
mers and probes (VIC-TAMRA) at 50 nM and 100 nM,
respectively. Primers and probes were designed using
the Primer Express software (Applied Biosystems, For-
ster City, CA, USA). The oligonucleotide sequences for
the primers and probes are shown in Table 2. The cycle
conditions were: 2 min at 50°C, 10 min at 95°C, 40
cycles of 15 sec at 95°C and 60 sec at 60°C. Threshold
CT values were set at 0.05. Baseline start and stop values
for the gene of interest were set at 3 and 15, respec-
tively, and for 18S rRNA at 3 and 7, respectively. mRNA
abundance was calculated using the comparative CT
method according to the manufacturer’sp r o t o c o l .
Shortly, ΔCT =C T [gene of interest]-C T [EC]a n d
ΔΔCT = ΔCT [rosiglitazone control cells]-ΔCT [treated
cells] .T h ef o l de x p r e s s i o nf o rt h eg e n eo fi n t e r e s tw a s
expressed as 2−CT.
Statistical analysis
Statistical significance of the mean differences between
treatment and positive control was tested by Student’s
t-test for unpaired values. P values less than 0.05 were
considered significant. ArrayScan
® results are shown as
mean ± SEM. Gene expression data are expressed as
fold change ± error (based on SEM).
Results
Cross-validation of Cellomics
® assay
with Oil Red O method
For validation of the Cellomics
® assay, the established
Oil Red O method was used as reference, and the accu-
mulation of intracellular lipid droplets was measured
with both methods. C3H10 T1/2 cells were differen-
tiated for 7 days using the PPARg agonist rosiglitazone,
at concentrations between 0.01 and 100 μM. Cells
grown in DM without rosiglitazone (negative control)
accumulated only a few small fat droplets. The average
number of fat droplets per cell increased from 0.5 (nega-
tive control) to 4.0 (positive control). The fat droplets
were both significantly brighter and larger (p < 0.001) in
cells incubated with 10 μM rosiglitazone.
To assess the quality and suitability of the new metho-
dology the assay windows (positive control (p)/negative
control (n)) and the estimated Z-factors (1- ((3 × (sp +
sn))/(| μp - μn |); s = sample means and s =s a m p l e
standard deviation) for the different assay parameters
Table 2 Sequences of primers and probes for different adipocyte specific genes used in real-time RT-PCR
Gene name Forward/Reverse Primer Probe
Adiponectin (Acrp30) 5’-GGCACTCCTGGAGAGAAGGG
5’-ATTCCAACATCTCCTGTCTCACC
5’-GAAAGGAGATGCAGGTCTTCTTGGTCCTA
Fatty acid binding protein 4, adipocyte type (aP2) 5’-GCGTGGAATTCGATGAAATCA
5’-CCCGCCATCTAGGGTTATGA
5’-CGCAGACGACAGGAAGGTGAAGAGC
Acetyl-CoA carboxylase (ACC1) 5’-TCACTCGCTTTGGAGGCAA
5’-CGCAGCGATGCCATTGT
5’-AGGGTCATAGAGAAGGTGCTCATCGCC
Lipoprotein lipase (LPL) 5’-GTGGCCGAGAGCGAGAAC
5’-AAGAAGGAGTAGGTTTTATTTGTGGAA
5’-TTCCCTTCACCCTGCCCGAGG
Hormone sensitive lipase (HSL) 5’-AAGACCACATCGCCCACAG
5’-CAGACACACTCCTGCGCATAG
5’-AGAGTCTGTGCGCCCCACGGA
Fatty acid synthase (FAS) 5’-TCATAAAGCAGTTTCTTGATGTGGA
5’-CAGGCTCTTCAGTGGCAGC
5’-CACAGCAAGGTGCTGGAGGCCC
Carnitine palmitoyl transferase b (CPT-1 b) 5’-CCAATCATCTGGGTGCTGG
5’-TAAGAGACCCCGTAGCCATCAT
5’-TGGCTTTGGTCCCGTGGCG
Glucose transporter 4 (Glut4) 5’-TCGGCTCTGACGATGGG
5’-CCAAGCCAGCTGAGAATACAG
5’-AACCCCCTCGGCAGCGAGTGACTG
Peroxisome proliferator activated receptor gamma
2a (PPARg 2a)
5’-CTATGAGCACTTCACAAGAAATTACCAT
5’-TCCATCACGGAGAGGTCCAC
5’- TCTGGCCCACCAACTTCGGAATCAG
Peroxisome proliferator activated receptor alpha
(PPARa)
5’-GCCTCAGGGTACCACTACGG
5’-GCCGAATAGTTCGCCGAA
5’-CACGCATGTGAAGGCTGTAAGGGCTT
CCAAT/enhancer binding protein alpha (C/EBPa) 5’-CGGTGCGGGCAAAGC
5’-TGCGTTCCCGCCGTAC
5’-AGAAGTCGGTGGACAAGAACAGCAAC
18S rRNA 5’-CGGCTACCACATCCAAGG
5’-CGGGTCGGGAGTGGGT
5’-TTGCGCGCCTGCTGCCT
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interpreted as an exceptional assay, whereas a value
between 0 and 0.5 is indicative of a marginal assay [19].
The Oil Red O method had an assay window of 2.3 and
a Z-factor of only -0.08; where 0.2% DMSO was used as
negative control and 100 μM rosiglitazone as maximum
positive control. In contrast, the Cellomics
® assay
resulted in a window of 6.8 and a Z-factor of 0.71 for
the Spot Count/Object parameter. During screening, an
assay window greater than 20 and an average Z-value of
0.65 was achieved with 10 μM rosiglitazone as positive
control and 0.2% DMSO as negative control, indicating
that the fluorescent method is a robust assay (CV Spot
Count/Object = 0.09) [19].
Rosiglitazone dose-dependently increased the number
of Oil Red O-stained lipid droplets (Figure 1A). To
quantify the microscopic findings, Oil Red O was eluted
from the fat droplets and measured spectro-photometri-
cally (Figure 2A). A differentiation plateau seemed to be
reached between 10 μM and 100 μMr o s i g l i t a z o n e ,
hence 100 μM values were used as references for calcu-
lations. The fluorescent stain BODIPY
® likewise enabled
measurement of rosiglitazone-dependent induction of
TG formation (Figure 1B). Both fat droplet number
(Spot Count/Object) and fat droplet intensity (Spot Avg
Intensity) concentration-dependently increased with
rosiglitazone (Figure 2B). Thus, our method proved
valid for detecting intracellular lipid accumulation.
Effects of substances on number of maturing
C3H10 T1/2 cells
Cell (or nuclei) number was considered to reflect cell
viability. Cells treated with different concentrations of
DHA, EPA, EGCG, HT, resveratrol, (all-E)-lycopene and
b-carotene had a similar nuclei count as control cells.
The number of cells was slightly reduced (< 20%) by
incubation with EGCG, HT, resveratrol and b-carotene
at the highest concentration (data not shown). This was
corroborated by the measurement of LDH activity in
supernatants after 7 days’ treatment. Only DHA and
EPA increased the LDH release at 25 μM( d a t an o t
shown). The data indicate that cell viability was not
impaired by the substances, although some of them
might have apoptotic effects at high concentrations.
PUFAs and b-carotene inhibit lipid accretion
in maturing adipocytes
Subsequently, the effects of test substances on lipid
accumulation in adipocytes were investigated using the
Cellomics
® method. Murine pre-adipocytes were differen-
tiated for 7 days (n = 10) in the absence or presence of
ω-3 PUFAs (DHA or EPA), carotenoids, (poly)-phenols,
and catechins. Incubation of rosiglitazone-treated C3H10
T1/2 cells with 25 μM DHA, 25 μME P A ,o r2μM b-caro-
tene, significantly decreased the number of lipid droplets
(Spot Count/Object) by 56%, 42% and 41%, respectively
(Figure 3). At 25 μM HT inhibited the accumulation of
TGs in adipocytes by 38%, whereas (all-E)-lycopene and
EGCG reduced the fat droplets by 22 and 7%, respectively.
The test compounds also lowered the spot intensity (Spot
Avg Intensity) and Spot Total Area/Object parameters to
a similar extent, suggesting that the total fat content per
cell was reduced. Compared to the PUFAs, resveratrol did
not affect adipogenesis and even increased TG content.
Concentration-dependent effects of test
compounds on TG accumulation
In order to investigate the concentration-response
relationship of the test substances, we differentiated pre-
adipocytes for 7 days in the presence of 3 concentrations
Figure 1 Visualisation of lipid accumulation in differentiated adipocytes. C3H10 T1/2 cells were treated for 7 days with rosiglitazone (0.01,
0.1, 1 and 10 μM) and, after fixation with 60% isopropanol, stained with A) Oil Red O or B) Hoechst 33342 and BODIPY
® 493/503. Images were
acquired using A) a Nikon Coolpix 990 camera at 20× magnification or B) the Cellomics
® HCS Reader camera (20×).
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dependently reduced both fat droplet number and intensity
(Figure 4). b-carotene showed a more potent concentra-
tion-dependency than (all-E-)-lycopene. EGCG and resver-
atrol, however, had no inhibitory effect on intracellular TG
accumulation (except EGCG at 25 μM; Figure 3). In
contrast, HT showed a similar concentration-dependent
modification of fat droplets as EPA (data not shown).
Reduced expression of genes involved in adipocyte
differentiation and in glucose and fatty acid metabolism
To explore a possible impact of the tested substances at
the transcriptional level, we differentiated pre-adipocytes
with 10 μM rosiglitazone in the absence or presence of
DHA, EPA, EGCG, HT, resveratrol, (all-E-)-lycopene or
b-carotene and assessed gene expression levels by quan-
titative RT-PCR. Tested genes were the master regula-
tors of adipogenesis PPARg and C/EBPa, the nuclear
receptor PPARa, as well as the adipocyte differentiation
markers fatty acid binding protein 2 (aP2) and adipose
tissue-specific adiponectin. mRNA levels of genes
involved in fatty acid metabolism (ACC1, CPT-1b,F A S ,
HSL, LPL) and glucose uptake (Glut4) were also
determined.
Treatment with DHA (25 μM) reduced the expression
of aP2 and adiponectin, to 48% and 59% respectively
(Table 3). The expression of aP2 and adiponectin after
treatment with 2 μM b-carotene was also significantly
decreased to 31% and 39%, and at 25 μMH Tt o4 7 %
and 69%, respectively (Figure 5, Table 3). The mRNA
levels of the adipogenesis-associated transcription
factors, PPARg, PPARa and C/EBPa were strongly sup-
pressed by PUFAs, b-carotene and HT at the highest
concentration (up to 85%; Table 3). Although PPARg
and C/EBPa were suppressed by b-carotene, as by DHA
and EPA, not exactly the same down-stream genes were
affected. Interestingly 1 μM DHA led to a significant
increase in the mRNA level of C/EBPa.
ACC1, CPT-1b, FAS, HSL and LPL are enzymes
which control triglyceride transport, fatty acid synthesis
and transport of long-chain fatty acids in differentiated
fat cells. In the case of CPT-1b, its expression was
significantly reduced by DHA to 21% and by HT to
44%, but not by lycopene (Table 3). The effects of DHA
and b-carotene on gene expression levels were concen-
tration-dependent (Figure 5). LPL mRNA levels were
strongly diminished to 10% by all b-carotene
concentrations.
With regard to the glucose transporter 4 gene (Glut4),
which is instrumental for adipocyte glucose uptake, the
investigated substances had an effect that was similar to
that observed for ACC1 (Figure 5). In particular, DHA
affected the gene expression of Glut4 in a dose-depen-
dent manner. Conversely, resveratrol slightly increased
mRNA levels of the investigated genes (Figure 5). This
is consistent with the effects on cell morphology
described above.
Discussion
T h ep r e s e n ts t u d yd e s c r i b e st h ea b i l i t yo fn a t u r a l
substances to modulate intracellular lipid accumulation
during adipogenesis. A high-content method for detect-
ing fat droplets in differentiating adipocytes is
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Figure 3 Effects of DHA, EPA, b-carotene, HT, (all-E)-lycopene,
EGCG and resveratrol on lipid formation measured with the
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scopic analysis, because the nuclei and the droplets can
be well visualised in separate fluorescent channels. As a
model system we selected a murine pluripotent cell line,
C3H10 T1/2, which could be readily differentiated into
adipocytes by treating the cells with the PPARg agonist
rosiglitazone and insulin.
The SpotDetector
® protocol from ThermoFisher was
modified to identify fat droplets with a radius of > 15
pixel (i.e. > 3.9 μm), therefore excluding small droplets
that are formed in pre-adipocytes only exposed to
DMSO and insulin. The adapted algorithm quantified
the effects of 10 μM rosiglitazone with high consistency,
yielding Z-factors > 0.6 for the nuclei-related parameters
Spot Count and Spot Area and for the parameter Spot
Average Intensity. Hence the Cellomics
® assay is suita-
ble for rapid screening of a large number of compounds
[19] and is amendable for a high throughput screen if
transferred to a 96-well-plate format. The consistent
measurements achieved with the SpotDetector
® BioAp-
plication also enabled detection of moderate effects of
less potent modulators such as bioactive components in
food. This high-content analysis (HCA) approach is a
greatly improved method (higher Z-factors, broader
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Figure 4 Effects of varying concentrations of DHA, EPA, b-carotene, (all-E)-lycopene, resveratrol and EGCG on number and intensity of
fat droplets. C3H10 T1/2 cells were differentiated in the presence of test substances for 7 days. Spot Count/Object and Spot Avg Intensity were
determined, as compared to rosiglitazone control set as 100%. Data are shown as mean ± SEM (n = 10 - 20). Student’s t-test: treatment versus
control (*) p < 0.05, (**) p < 0.01, (***) p < 0.001.
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Page 7 of 13window and small CVs) compared with the commonly-
used Oil Red O procedure, delivering fast, multi-
parametric and objective data in a labour-reduced
manner. Its use is comparable with the system presented
by McDonough and co-workers [20], who applied the
CyteSeer
® image analysis software (Vala Sciences),
together with a robotic microscopy instrument. However,
the convenient use of commercially available cell culture
plates, the easily applicable lipid stain (BODIPY
® 493/
503) and rapid field-based analysis of images with the
provided BioApplication from ThermoFisher are advan-
tageous for the fast quantification of fat droplets in
adipocytes.
A large number of studies suggest that certain plant
extracts, their constituent phytochemicals [8,21] and the
fatty acid composition of fats [22], influence the meta-
bolism in adipocytes [23]. Based on this information we
tested several bioactive substances present in our daily
diet with the established HCA assay.
The ω-3 PUFAs EPA and DHA, which are known to
reduce lipid droplet size in differentiating 3T3-L1
pre-adipocytes [9,24] and to decrease adipose growth in
rodents [25-28], were tested as reference compounds
in our assay. ω- 3P U F A sm a r k e d l yr e d u c e dt h en u m b e r
of fat droplets and their average intensity in a dose-
dependent manner whereas size of the lipid droplets
Table 3 Effects of compounds on gene expression of adipocyte differentiation markers and enzymes involved in fat
and glucose metabolism (n = 6 - 15)
PUFAs CAROTENOIDS PHENOLS
DHA
25 μM
EPA
25 μM
lycopene
2 μM
b-carotene
2 μM
EGCG
25 μM
HT
25 μM
Resv
25 μM
PPARg2 fold 0.48 0.61 0.93 0.48 0.97 0.53 1.07
error +/- 0.11/0.09 0.09/0.08 0.33/0.25 0.17/0.13 0.20/0.17 0.15/0.12 0.12/0.11
p-value < 0.001 0.002 0.75 0.04 0.64 < 0.001 0.53
PPARa fold 0.15 0.25 1.01 0.80 0.81 0.47 0.92
error +/- 0.10/0.06 0.10/0.07 0.57/0.36 0.37/0.25 0.11/0.09 0.15/0.12 0.07/0.07
p-value < 0.001 < 0.001 0.94 0.69 0.33 < 0.001 0.99
C/EBPa fold 0.60 0.82 0.86 0.42 1.02 0.46 1.12
error +/- 0.09/0.08 0.08/0.07 0.34/0.24 0.29/0.17 0.13/0.12 0.15/0.11 0.07/0.07
p-value < 0.001 0.038 0.12 0.02 0.94 < 0.001 0.44
aP2 fold 0.52 0.72 1.09 0.31 0.82 0.47 1.06
error +/- 0.13/0.11 0.05/0.05 0.13/0.12 0.25/0.14 0.07/0.07 0.15/0.11 0.07/0.06
p-value < 0.001 0.005 0.26 0.007 0.04 < 0.001 0.45
Acrp30 fold 0.41 0.61 0.85 0.39 0.84 0.69 1.11
error +/- 0.13/0.10 0.12/0.10 0.11/0.10 0.39/0.19 0.09/0.08 0.08/0.07 0.14/0.13
p-value < 0.001 0.002 0.06 0.02 0.79 < 0.001 0.11
Glut4 fold 0.25 0.39 1.33 0.37 0.86 0.42 1.04
error +/- 0.10/0.07 0.09/0.08 0.21/0.18 0.42/0.20 0.17/0.15 0.07/0.06 0.20/0.17
p-value < 0.001 < 0.001 0.04 0.06 0.33 < 0.001 0.47
LPL fold 0.39 0.62 0.41 0.10 0.63 0.77 0.73
error +/- 0.17/0.12 0.13/0.10 0.35/0.19 0.40/0.08 0.28/0.19 0.12/0.11 0.59/0.33
p-value < 0.001 0.013 0.09 0.005 0.01 0.13 0.18
FAS fold 0.63 0.65 0.79 0.68 1.13 0.83 1.05
error +/- 0.05/0.05 0.05/0.05 0.19/0.15 0.06/0.06 0.19/0.17 0.07/0.07 0.07/0.07
p-value < 0.001 0.02 0.14 0.04 0.37 0.08 0.37
HSL fold 0.58 0.75 0.91 0.49 1.04 0.69 1.05
error +/- 0.11/0.09 0.11/0.10 0.06/0.06 0.28/0.18 0.10/0.09 0.09/0.08 0.07/0.07
p-value < 0.001 0.016 0.58 0.04 0.69 < 0.001 0.30
CPT-1b fold 0.21 0.34 1.11 0.59 0.81 0.44 0.84
error +/- 0.09/0.06 0.11/0.08 0.28/0.22 0.27/0.18 0.10/0.09 0.06/0.05 0.09/0.08
p-value < 0.001 < 0.001 0.23 0.35 0.08 < 0.001 0.47
ACC1 fold 0.57 0.64 0.90 0.88 1.46 0.68 1.17
error +/- 0.14/0.11 0.14/0.11 0.30/0.23 0.01/0.01 0.34/0.27 0.15/0.13 0.19/0.17
p-value 0.004 0.02 0.58 0.72 0.09 0.02 0.45
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FAT ACCUMULATION
fat droplet number % 87.1 79.4 44.3 82.5 72.9 58.7 98.1 103.9 97.6
SEM 5.5 5.0 7.0 3.9 9.4 13.7 3.8 1.9 2.7
fat droplet intensity % 87.3 66.7 56.9 77.2 63.3 56.2 99.7 94.2 93.6
SEM 3 . 93 . 53 . 64 . 24 . 54 . 44 . 63 . 23 . 8
fat droplet area % 82.1 72.7 42.0 89.7 93.1 71.7 96.6 102.8 105.6
SEM 4.7 4.8 7.1 5.1 10.6 16.3 3.5 2.0 3.1
GENE EXPRESSION
fat metabolism
LPL fold 1.14 0.89 0.39*** 0.09** 0.07** 0.1** 1.06 1.14 0.73
error + 0.09 0.05 0.17 0.52 0.52 0.40 0.05 0.17 0.59
error - 0.09 0.05 0.12 0.08 0.06 0.08 0.04 0.15 0.33
ACC1 fold 1.17 0.90 0.57** 1.07 0.82 0.88 1.32 1.43* 1.17
error + 0.10 0.07 0.14 0.17 0.19 0.01 0.34 0.51 0.19
error - 0.10 0.06 0.11 0.15 0.16 0.01 0.27 0.38 0.17
CPT-1E fold 1.05 0.73 0.21*** 0.96 0.73 0.59 1.06 1.00 0.84
error + 0.06 0.02 0.09 0.13 0.10 0.27 0.17 0.16 0.09
error - 0.05 0.02 0.06 0.11 0.09 0.18 0.15 0.14 0.08
* < 0.05
** < 0.01
*** < 0.001
transcription factors
PPARD fold 1.01 0.64* 0.15*** 0.94 0.88 0.80 1.40 1.29 0.92
error + 0.07 0.09 0.10 0.21 0.14 0.37 0.26 0.14 0.07
error - 0.07 0.08 0.06 0.17 0.12 0.25 0.22 0.12 0.07
C/EBPD fold 1.21* 1.10 0.60*** 0.88 0.75 0.42* 1.12 1.24 1.12
error + 0.01 0.07 0.09 0.05 0.14 0.29 0.09 0.11 0.07
error - 0.01 0.06 0.08 0.05 0.12 0.17 0.08 0.10 0.07
differentiation markers
aP2 fold 1.00 1.01 0.52*** 0.86 0.66 0.31** 1.13* 1.22* 1.06
error + 0.04 0.05 0.13 0.08 0.19 0.25 0.04 0.12 0.07
error - 0.04 0.04 0.10 0.07 0.15 0.14 0.04 0.11 0.06
adiponectin fold 1.17 0.97 0.41*** 0.71 0.59 0.39* 1.16 1.07 1.11
error + 0.08 0.05 0.13 0.15 0.26 0.39 0.18 0.16 0.14
error - 0.08 0.04 0.10 0.12 0.18 0.19 0.15 0.14 0.13
glucose uptake
Glut4 fold 1.18 0.89 0.25*** 0.76 0.63 0.37 1.07 1.24 1.04
error + 0.17 0.03 0.10 0.14 0.19 0.42 0.14 0.23 0.20
error - 0.15 0.03 0.07 0.11 0.14 0.20 0.12 0.19 0.17
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Figure 5 Summary of overall effects of the dietary ingredients DHA, b-carotene and resveratrol on lipid accumulation and on
gene expression clusters. mRNA levels of enzymes involved in glucose and fat metabolism (Glut4, LPL, FAS, ACC1 and CPT-1b) and of adipocyte
differentiation markers (PPARg, C/EBPa, PPARa, aP2 and adiponectin) were determined in maturing C3H10 T1/2 cells. Depicted are the dose-
dependent effects of DHA and b-carotene and the impact of resveratrol on lipid accumulation (after 7 days treatment, top of the table) and on gene
expression (after 4 days treatment) relative to rosiglitazone control cells. Data are shown as % of positive control ± SEM (fat accumulation parameters)
and fold change ± error (based on SEM, n = 6 - 15) for gene expression levels, respectively. Exemplarily, the fold changes of the genes FAS and PPARg
are shown as illustration. Fat droplet number equates to Spot Count/Object; fat droplet intensity equates to Spot Avg Intensity and fat droplet area
equates to Spot Total Area/Object. Student’s t-test: treatment versus control (*) p < 0.05, (**) p < 0.01, (***) p < 0.001. The average coefficient of
variation (CV) for dCT values was less than 5% for all analysed genes at all concentration of the investigated compounds.
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Page 9 of 13was not decreased (data not shown). By comparison,
Madsen et al. [9] used a mix of dexamethasone, 3-isobu-
tyl-1-methylxanthine (IBMX) and insulin for the differen-
tiation of 3T3-L1 cells and compared whether different
PUFAs enhanced adipocyte differentiation to a similar
extent as the PPARg agonist rosiglitazone. DHA and EPA
were reported to be less potent than rosiglitazone. Because
we used only rosiglitazone and insulin for differentiation,
one could expect that the concomitant treatment with
DHA or EPA would further stimulate the TG accretion.
Interestingly in maturing C3H10 T1/2 cells we observed
the opposite effect. At which stages of the adipocyte life
cycle (determination, clonal expansion, maturation, lipoly-
sis or apoptosis) [2] the ω-3 PUFAs affect the reduction of
lipid droplets in C3H10 T1/2 could not be deduced from
the ArrayScan
® results. The elevated LDH levels after
7 days’ treatment might indicate that DHA induced apop-
tosis during clonal expansion as described for 3T3-L1 cells
[29]. Thus, the potent inhibition of lipid accumulation is
not only due to decreased adipogenesis but might also
reflect a pro-apoptotic effect of DHA.
In addition, we showed that EPA and DHA reduced
expression levels of adipogenic and lipogenic genes as
described by Raclot et al. [30] and Shillabeer et al.[ 3 1 ] .
C/EBPa and PPARg are the ‘master’ regulators of adipo-
genesis [32]. PPARg regulates the anabolic arm of lipid
metabolism [33], whereas PPARa [5,34] and PPARb/δ
are effective as catabolic modulators of the energy bal-
ance [35]. PPARg and PPARa a r ei n d u c e di nt h ee a r l y
and late phases of the differentiation process, respec-
tively [36,33], and act as sensors for fatty acids and their
derivatives [37,38]. Our findings that C3H10 T1/2 adi-
pocytes, differentiated in the presence of DHA or EPA,
show only a weak C/EBPa and PPARg expression, are in
line with the results of Worgall et al.: PUFAs down-
regulated the expression of sterol regulatory element-
binding proteins (SREBPs), which play a major role in
adipocyte differentiation [39], regulate PPARg,a n d
thereby suppress lipogenesis [40]. Moreover, Okuno et
al.d e m o n s t r a t e dt h a tω-3 PUFAs also down-regulated
genes of the late phase of adipocyte differentiation, such
as PPARa and aP2 in rat visceral adipose tissue [27].
We hypothesise that the reduced expression levels of
these two genes and other enzymes and transporters
important for lipid and glucose metabolism, such as
LPL, FAS, CPT-1b and Glut4, are a consequence of
DHA inhibiting the two master regulators PPARg and
C/EBPa and thus suppressing adipogenesis and conco-
mitant lipogenesis in C3H10 T1/2 cells. Collectively, our
data are both consistent with and extend earlier studies
performed in 3T3-L1 cells [41,29,24].
Furthermore a large body of studies concerning
b-carotene and lycopene, EGCG and resveratrol
demonstrates that the effects of natural compounds on
adipocyte differentiation are as varying as their structure
[23]. EGCG, the major catechin in green tea, is known
to stimulate apoptosis, inhibit adipogenesis and intracel-
lular TG accretion in 3T3-L1 adipocytes [42,43]. Human
AML-1 cells undergo apoptosis after treatment with
EGCG, although the conversion from pre-adipocytes to
adipocytes is not affected [44]. Moreover, EGCG had no
lipolytic influence on mature C3H10 T1/2 adipocytes
[45]. Our results show that EGCG only moderately
inhibited the average intensity of the fat droplets in
C 3 H 1 0T 1 / 2c e l l sa n di th a dn os i g n i f i c a n ti m p a c to n
any gene expression levels, although Furuyashiki et al.
[43] reported that in 3T3-L1 cells PPARg and C/EBPa
were down-regulated by tea catechins, like EGCG.
These also showed an enhancing effect on the expres-
sion and secretion of adiponectin in 3T3-L1 adipocytes
[46]. However, in maturing C3H10 T1/2 adipocytes the
mRNA level of adiponectin was not affected by EGCG.
Investigations on the protein level and of the cell super-
natants are required to further determine the effects of
dietary constituents on secreted adipokines.
Resveratrol has been tested on adipocytes [47] and was
found to be apoptotic [48], anti-adipogenic [48,49] and
anti-lipogenic [21]. In this study resveratrol showed no
inhibitory effect, or even induced a moderate stimulation
of lipid accumulation in differentiating C3H10 T1/2 cells.
This is consistent with the observed up-regulation of aP2
mRNA at low resveratrol concentrations, compared to
rosiglitazone control. In contrast, Rayalam et al.[ 4 8 ]
reported suppression of adipocyte-specific genes such as
PPARg,C / E B P a, FAS, HSL and LPL and a strong inhibi-
tion of lipid accumulation (40% by 25 μM resveratrol) in
maturing 3T3-L1 adipocytes. These effects were
accounted for by decreased cell viability.
Reduced cell number and increased LDH levels are
indicative of apoptosis and reduced cell viability [48].
Consequently, a diminished number of fat cells during
differentiation enable less fat accumulation. It can be
assumed that b-carotene induced apoptosis at 2 μM
similar to EGCG at 25 μM (data not shown, [42]). At this
physiologically-relevant concentration b-carotene effi-
ciently reduced fat droplet number, size and intensity.
Furthermore b-carotene treatment led to a down-regula-
tion of the dominant regulators of adipogenesis, PPARg
and C/EBPa, and a significant reduction of LPL, HSL,
FAS, aP2 and adiponectin. The effects of b-carotene and
its biologically active form vitamin A (retinol/retinal/
retinoic acid) on WAT are well-studied (for review see
[50]). Kawada and co-workers [51] described that fat
soluble vitamins, including provitamin b-carotene,
strongly inhibited adipose conversion of 3T3-L1 cells.
They [52] suggested that carotenoids and retinoids
inhibit adipocyte differentiation through retinoic acid
receptor up-regulation and the decrease of PPARg2. The
Warnke et al. Nutrition & Metabolism 2011, 8:30
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Page 10 of 13strong suppression of LPL, one of the early markers of
adipocyte differentiation [53], is remarkable compared to
all the other dose-dependent effects of b-carotene.
Insulin is known to induce LPL synthesis in adipocytes
and stimulate LPL, ACC and Glut4 proteins. Plausibly,
b-carotene - even in low concentrations - interferes with
insulin actions, although recently it was shown by Kameji
et al. [54] that high concentrations of b-carotene elevated
LPL and PPARg levels and insulin functions were sup-
ported. Lycopene, as a fat-soluble molecule is also stored
in adipose tissue, in particular in different cellular com-
partments of the adipocytes [55]. Our results illustrate
that lycopene decreased the accumulation of TGs to a far
lesser extent than b-carotene and it also showed no effect
on the different adipogenic and lipogenic genes. Only
Glut4, which participates in insulin-dependent glucose
uptake into adipocytes [56] and is thus indirectly
involved in fatty acid synthesis, was significantly reduced.
Therefore, the small effect it has must be mediated via
other mechanisms than PPARg and C/EBPa suppression.
Hydroxytyrosol (HT) is the major polyphenol in extra-
virgin olive oil and its potent antioxidant properties are
thought to be partly responsible for the Mediterranean
diet effect [57,58]. In our study, HT showed effects that
were comparable to those of EPA and b-carotene on
adipocyte lipid content and gene expression. HT signifi-
cantly inhibited all tested genes except LPL.
In summary, dietary bioactives such as ω-3 PUFAs,
b-carotene and HT, which seem to have the same inhi-
bitory effect on lipid accumulation during adipocyte dif-
ferentiation, display different impacts on the expression
of relevant genes. Therefore, the influence of substances
on the phosphorylation status of corresponding
enzymes, e.g. LPL and HSL, should also be considered.
The conflicting data reported in different studies might
be partly explained by the use of different cell models
from different species. Adipose tissue biology is diversely
regulated among different species, thus the same might
be applicable for different cell lines. Contradictory effects
of substances in diverse cell systems could be explained
due to the application of cAMP elevating agents, the hor-
monal status (e.g. dexamethasone and insulin) present
during adipocyte differentiation [9] and the stage of the
adipocyte life cycle at which they are applied [23].
Conclusion
Obesity is characterised by increased adipose tissue mass
and is associated with high health risks. The expansion
of WAT is conditional upon its ability to increase the
number of adipocytes and their volume (triglyceride
content in fat droplets). Identifying compounds that
suppress the formation of new adipocytes and the accre-
tion of fat at different stages of the adipocyte life cycle
is of major interest for preventive measures and
therapeutic applications. Our data show that this newly
developed HCA assay is a valuable tool to identify and
quantify changes in fat accumulation during adipogen-
esis and lipogenesis and thus for the identification of
such substances. This study demonstrates that treatment
o fm u r i n eC 3 H 1 0T 1 / 2p r e - a d i pocytes with naturally-
occurring components can reduce the amount of accu-
mulated fat. Furthermore, the observed morphological
changes are in line with the alterations in expression
levels of adipogenic and lipogenic genes.
Murine cell lines might give indications how food
ingredients influence the formation of fat droplets in tis-
sues. This needs, however, to be further corroborated by
experiments with human adipocytes. Ultimately, studies
with obese humans would be of great value, as obesity is
not only caused by high fat consumption but also trig-
gered by high intakes of refined carbohydrates [9]. Other
research groups approach this challenge and discovered
both differences and analogies in human and rodent adi-
pogenesis [59]. For example Söhle et al. describes that a
white tea extract rich in polyphenols inhibited the adipo-
genesis in human subcutaneous pre-adipocytes [60].
Because several natural compounds act in different
ways on the elaborate biological pathways of adipose
tissue formation, it would be advantageous to treat
adipocytes with a combination of dietary bioactives.
Hence, such an approach might exceed the favourable
effects of each individual compound and lead to additive
or synergistic effects on multiple levels of adipocyte dif-
ferentiation. This strategy might also apply for improving
the appearance of dimpled skin caused by overfilled sub-
cutaneous adipocytes mostly observed in obese people.
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